Scarica l'app Stockscreener
29.81
7.04%
1.96
Dopo l'orario di chiusura:
29.86
0.05
+0.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Precedente Chiudi:
$27.85
Aprire:
$28.68
Volume 24 ore:
11.57M
Relative Volume:
0.74
Capitalizzazione di mercato:
$6.51B
Reddito:
$1.24B
Utile/perdita netta:
$101.26M
Rapporto P/E:
67.75
EPS:
0.44
Flusso di cassa netto:
$149.62M
1 W Prestazione:
+13.74%
1M Prestazione:
+13.78%
6M Prestazione:
+53.50%
1 anno Prestazione:
+258.29%
Intervallo 1D:
$28.01
$30.00
Intervallo di 1 settimana:
$25.56
$30.00
Portata 52W:
$8.44
$35.02
Hims Hers Health Inc Stock (HIMS) Company Profile
Nome
Hims Hers Health Inc
Settore
Industria
Telefono
415-851-0195
Indirizzo
2269 CHESTNUT ST, SAN FRANCISCO
Confronta HIMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
29.81 | 6.51B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
161.72 | 379.90B | 83.91B | 14.32B | 15.85B | 5.80 |
|
UL
Unilever Plc Adr
|
56.91 | 140.75B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
88.23 | 72.08B | 20.11B | 2.87B | 3.40B | 3.49 |
|
KMB
Kimberly Clark Corp
|
126.52 | 42.19B | 20.10B | 2.61B | 2.90B | 7.71 |
|
KVUE
Kenvue Inc
|
20.80 | 39.88B | 15.46B | 1.06B | 1.40B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Downgrade | Citigroup | Neutral → Sell |
| 2025-01-07 | Iniziato | BTIG Research | Buy |
| 2024-12-17 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-08-22 | Iniziato | Needham | Buy |
| 2024-08-09 | Downgrade | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-04-16 | Downgrade | Jefferies | Buy → Hold |
| 2024-04-10 | Iniziato | Canaccord Genuity | Buy |
| 2024-02-28 | Aggiornamento | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | Imperial Capital | In-line |
| 2023-07-28 | Iniziato | TD Cowen | Outperform |
| 2023-04-11 | Iniziato | Robert W. Baird | Neutral |
| 2023-02-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-08 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-07-15 | Iniziato | SVB Leerink | Underperform |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-10 | Iniziato | Deutsche Bank | Hold |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-11-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Iniziato | BofA Securities | Neutral |
| 2021-05-20 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Iniziato | Truist | Hold |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-03-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Iniziato | Citigroup | Neutral |
| 2021-02-12 | Iniziato | Piper Sandler | Neutral |
| 2021-02-08 | Iniziato | Tigress Financial | Buy |
Mostra tutto
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Hims & Hers CEO Andrew Dudum sells $2.27 million in stock - Investing.com
Hims & Hers Health Unusual Options Activity - Benzinga
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Sold by Diversify Advisory Services LLC - MarketBeat
Hims & Hers Health Stock Climbs Following Q4 Earnings Beat, Revenue Beat, Guidance Above Estimates - MSN
Hims & Hers Health: A Stock to Trade or Own? - MSN
Hims & Hers: Ready To Outperform Further - Seeking Alpha
Hims & Hers Health: The Market Is Likely Wrong (NYSE:HIMS) - Seeking Alpha
Lake Street Private Wealth LLC Increases Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Oak Ridge Investments LLC Reduces Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Short Interest Update - MarketBeat
Hims & Hers Health (NYSE:HIMS) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Hims & Hers Health down 3% after BoA says Q4 revenue could be a miss - MSN
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today - sharewise
Noteworthy Friday Option Activity: UNH, HIMS, IGT - Nasdaq
BofA retains Hims & Hers stock rating amid pharma challenges - MSN
Hims & Hers Health Inc (HIMS) Shares Gap Down to $26.8776 on Jan 17 - GuruFocus.com
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today - The Motley Fool
Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by Carnegie Investment Counsel - MarketBeat
CHURCHILL MANAGEMENT Corp Purchases Shares of 18,392 Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health (NYSE:HIMS) rises 8.3% this week, taking three-year gains to 474% - Simply Wall St
Is Hims & Hers Stock in Trouble? - MSN
(HIMS) Long Term Investment Analysis - Stock Traders Daily
Investors in Hims & Hers Health (NYSE:HIMS) have seen enviable returns of 440% over the past three years - Yahoo Finance
Hims & Hers CFO sells shares worth $283,083 By Investing.com - Investing.com Nigeria
Hims & Hers health chief commercial officer sells $174,724 in stock - Investing.com Nigeria
Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 7,259 Shares of Stock - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells $283,039.64 in Stock - MarketBeat
Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's Why - MSN
Hims & Hers health chief commercial officer sells $174,724 in stock By Investing.com - Investing.com South Africa
DOCS: 3 Telemedicine Stocks Making Healthcare More Accessible - StockNews.com
Hims & Hers in focus as Eli Lilly obesity drug sales disappoint - MSN
Hims & Hers stock up as Eli Lilly GLP-1 sales miss (LLY:NYSE) - Seeking Alpha
What’s Behind This Telehealth Stock’s 198% Rally? - substack.com
Hims & Hers Health down as Citi downgrades on GLP-1 revenue stream overvaluation - MSN
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment - Benzinga
GAMMA Investing LLC Buys 2,152 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
A 100x stock: Hims & Hers ($HIMS) - substack.com
Hims & Hers Health (NYSE:HIMS) Stock Rating Lowered by Citigroup - Defense World
Why Hims & Hers Health Stocks Are Dropping - TipRanks
Hims & Hers Stock Is Poised for a Major Surge in 2025 - MSN
Hims & Hers Health Inc (HIMS) Stock Price Down 4.82% on Jan 10 - GuruFocus.com
Hims & Hers Health (NYSE:HIMS) Shares Gap DownTime to Sell? - MarketBeat
Hims & Hers Stock Is Poised For A Major Surge In 2025 - Barchart
HIMS downgraded, agilon upgraded at Citi in 2025 Health Tech review - Seeking Alpha
Hims Hers Health Inc Azioni (HIMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.66%
0.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):